DHC - NASDAQ

Diversified Healthcare Trust

DHC·NASDAQ

$8.59

+0.62%

Real EstateREIT - Healthcare Facilities

DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.08B

EPS-1.1900

P/E Ratio-7.22

Earnings Date08/03/2026

1.54B

Revenue

3Y+20.0%

5Y-6.0%

10Y+45.0%

-285.89M

Net Income

-23%

3Y+1712.0%

5Y+105.0%

10Y-302.0%

-19.62M

Operating Cash Flow

-117%

3Y-51.0%

5Y-112.0%

10Y-105.0%

Diversified Healthcare Trust Profit Bridge

DHC · NASDAQ

Revenue & Cost of Sales

Revenue1.54B

Cost of Goods Sold (1.78B)

Gross Profit-245.33M

Operating Expenses

Operating Expenses (-206.06M)

Operating Income-39.27M

Other Income & Taxes

Interest Expense (204.50M)

Other Income/Expense-244.88M

Pretax Income-284.14M

Income Tax (1.74M)

Net Income-285.89M

Net Income

-285.89M

Profitability Analysis

Gross Margin

-16.0%

Negative gross margin indicates the company is losing money on each sale—unsustainable long-term.

Operating Margin

-2.6%

Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.

Net Profit Margin

-18.6%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Critical situation: Negative gross margins indicate fundamental business model issues. The company loses money on every sale—immediate strategic changes required.

Diversified Healthcare Trust Income Statement

DHC • NASDAQ

Diversified Healthcare Trust Income Statement	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
REVENUE
Revenue	1.5B	1.5B	1.4B	1.3B	1.4B	1.6B	1B	1.1B	1.1B	1.1B	998.8M	844.9M	761.4M	634.8M	450M	339M	297.8M	235.5M	188M	179.8M
GROSS PROFIT
Cost of Revenue	(1.8B)	(1.2B)	(1.2B)	(1.1B)	(1.1B)	(1.2B)	(502.2M)	(451.8M)	(413.9M)	(401.9M)	(384.4M)	(329.2M)	(303.3M)	(207.1M)	(69M)	(19.2M)	(14.3M)	(2.8M)	(85.3M)	(21K)
Gross Profit	-245.3M	256.4M	225.3M	174.5M	291.4M	394.9M	538M	665.4M	660.8M	656.1M	614.3M	515.7M	458.2M	427.7M	381.1M	319.8M	283.5M	232.7M	102.7M	179.8M
OPERATING INCOME
Operating Expenses	-206.1M	(26.5M)	(26.1M)	(265.7M)	(305.2M)	(30.6M)	(37M)	(85.9M)	(103.7M)	(46.6M)	(300.8M)	(224.3M)	(193.7M)	(178.6M)	(139.3M)	(112.3M)	(102.3M)	(89.1M)	(61.5M)	(58.7M)
Selling, General & Administrative	(45.5M)	(26.5M)	(26.1M)	(26.4M)	(34.1M)	(30.6M)	(37M)	(85.9M)	(103.7M)	(46.6M)	(42.8M)	(38.9M)	(32.7M)	(31.5M)	(26M)	(21.9M)	(23.7M)	(17.1M)	(14.2M)	(14.6M)
Operating Income	-39.3M	229.9M	199.2M	-91.2M	-13.8M	364.3M	501M	579.5M	557.1M	609.6M	313.5M	291.4M	264.5M	257.2M	227.5M	203.9M	109.3M	106.2M	123.5M	113.1M
PRE-TAX INCOME
Interest Expense	(204.5M)	(235.2M)	(191.8M)	(209.4M)	(255.8M)	(201.5M)	(180.1M)	(179.3M)	(165M)	(167.6M)	(150.9M)	(135.1M)	(117.8M)	(117.2M)	(98.3M)	(80M)	(56.4M)	(40.2M)	(37.8M)	(47M)
Net Interest Income	-204.5M	-226.3M	-176.2M	-193.5M	-235.1M	-183.3M	-179.2M	-178.6M	-164.6M	-167.1M	-150.5M	-134.8M	-117.4M	-116.1M	-96.8M	-79.2M	-55.4M	-40.2M	-37.8M	-45.6M
Other Expenses	-251.6M	(0.0)	(0.0)	(239.3M)	(271.1M)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(258M)	(185.4M)	(161M)	(0.0)	(139.3M)	(112.3M)	(98.9M)	(78M)	(47.4M)	(44.1M)
Total Other Income Expenses Net	-244.9M	-599.6M	-492.3M	76.2M	195.2M	-497.3M	-583.4M	-286.6M	-404.9M	-467.9M	-188M	-129.2M	-80.2M	-125M	-75.8M	-87.1M	-58M	266K	-38.2M	-47M
Income Before Tax	-284.1M	-369.8M	-293.1M	-15.1M	181.4M	-133.1M	-82.4M	292.9M	152.3M	141.7M	125.5M	162.2M	184.3M	132.2M	151.7M	116.8M	109.7M	106.5M	85.3M	66.1M
NET INCOME
Income Tax Expense	(1.7M)	(467K)	(445K)	(710K)	(1.4M)	(1.3M)	(436K)	(476K)	(454K)	(424K)	(574K)	(576K)	(600K)	(375K)	(312K)	(300K)	(71.5M)	(0.0)	(0.0)	(0.0)
Net Income	-285.9M	-370.3M	-293.6M	-15.8M	174.5M	-139.5M	-88.2M	286.9M	147.6M	141.3M	124M	158.6M	151.2M	131.8M	151.4M	116.5M	109.7M	106.5M	85.3M	66.1M

SEC Filings

DHC - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 01, 2026	June 01, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 04, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 04, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 19, 2026	June 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 24, 2026	February 24, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 24, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 23, 2026	February 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 14, 2026	January 09, 2026	2026	View Filing
8-K 8-K 2025 N/A	January 05, 2026	December 31, 2025	2025	View Filing

Showing 1 to 10 of 453 filings

Related Guides

Blog Categories

Continue your DHC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.